193 related articles for article (PubMed ID: 28972294)
21. [Analysis of the differences in the expression of HSP27 and c-kit between benign prostatic hyperplasia and prostatic cancer tissues].
Zhen B; Shen Y; Zhang YM; Zhu CH; Liu ZL
Zhonghua Nan Ke Xue; 2006 May; 12(5):416-20. PubMed ID: 16755871
[TBL] [Abstract][Full Text] [Related]
22. [Expression of PIM-1 in prostate cancer tissue and its relationship with PSA recurrence].
Zhang CT; Xu Y; Luo F; Zhang ZH; Liu RL; Yang K; Ma BJ
Zhonghua Nan Ke Xue; 2012 Apr; 18(4):323-6. PubMed ID: 22574367
[TBL] [Abstract][Full Text] [Related]
23. Comparative Expression of RAGE and SOX2 in Benign and Malignant Prostatic Lesions.
Aboushousha T; Lashen R; Abdelnaser K; Helal N; Moussa M; Omran Z; Eldahshan S; El Ganzoury H
Asian Pac J Cancer Prev; 2019 Feb; 20(2):615-620. PubMed ID: 30806068
[TBL] [Abstract][Full Text] [Related]
24. Expression of some selected cytokeratins and Ki67 protein in prostatic tumor: can these be used as tumor markers.
Adisa JO; Egbujo EC; Ibrahim B; Musa B; Madukwe J
Pan Afr Med J; 2015; 20():46. PubMed ID: 26090004
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
26. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
[TBL] [Abstract][Full Text] [Related]
27. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
28. [Expressions of E-cadherin and alpha-catenin in benign, malignant and metastatic prostate tumors].
Jiang T; Jiang H; Su XM; Zheng L; Li QL; Zhang ZW; Li XC
Zhonghua Nan Ke Xue; 2012 Jun; 18(6):499-503. PubMed ID: 22774602
[TBL] [Abstract][Full Text] [Related]
29. Different perforin expression in peripheral blood and prostate tissue in patients with benign prostatic hyperplasia and prostate cancer.
Tokmadžić VS; Tomaš MI; Sotošek S; Laškarin G; Dominović M; Tulić V; Dorđević G; Sustić A; Mrakovčić-Šutić I
Scand J Immunol; 2011 Oct; 74(4):368-76. PubMed ID: 21535078
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
31. [Clinical significance of six-transmembrane epithelial antigen of the prostate expressed in prostatic carcinoma].
Li L; Li J; Shen Z; Liu W; Chen Z
Zhonghua Nan Ke Xue; 2004 May; 10(5):351-4. PubMed ID: 15190827
[TBL] [Abstract][Full Text] [Related]
32. Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.
Zhang CY; Zhu Y; Rui WB; Dai J; Shen ZJ
Asian J Androl; 2015; 17(1):106-10. PubMed ID: 25219913
[TBL] [Abstract][Full Text] [Related]
33. Nuclear overexpression levels of MAGE-A3 predict poor prognosis in patients with prostate cancer.
Khalvandi A; Abolhasani M; Madjd Z; Shekarabi M; Kourosh-Arami M; Mohsenzadegan M
APMIS; 2021 Jun; 129(6):291-303. PubMed ID: 33743542
[TBL] [Abstract][Full Text] [Related]
34. TRPM4 protein expression in prostate cancer: a novel tissue biomarker associated with risk of biochemical recurrence following radical prostatectomy.
Berg KD; Soldini D; Jung M; Dietrich D; Stephan C; Jung K; Dietel M; Vainer B; Kristiansen G
Virchows Arch; 2016 Mar; 468(3):345-55. PubMed ID: 26590985
[TBL] [Abstract][Full Text] [Related]
35. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of Low density lipoprotein Receptor-related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions.
Gilardoni MB; Remedi MM; Oviedo M; Dellavedova T; Sarría JP; Racca L; Dominguez M; Pellizas CG; Donadio AC
Pathol Res Pract; 2017 Jan; 213(1):66-71. PubMed ID: 27931798
[TBL] [Abstract][Full Text] [Related]
37. [Expression and its significance of b-FGF in human benign prostatic hyperplasia and prostatic carcinoma tissues].
Wang FL; Wang H; Qin WJ; Wu GJ; Zhang G; Li KN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar; 20(2):203-5. PubMed ID: 15191726
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of Cdc20 in clinically localized prostate cancer: Relation to high Gleason score and biochemical recurrence after laparoscopic radical prostatectomy.
Mao Y; Li K; Lu L; Si-Tu J; Lu M; Gao X
Cancer Biomark; 2016; 16(3):351-8. PubMed ID: 26889981
[TBL] [Abstract][Full Text] [Related]
39. Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry.
Cazares LH; Adam BL; Ward MD; Nasim S; Schellhammer PF; Semmes OJ; Wright GL
Clin Cancer Res; 2002 Aug; 8(8):2541-52. PubMed ID: 12171882
[TBL] [Abstract][Full Text] [Related]
40. [Vinculin and the androgen receptor in prostate cancer: expressions and correlations].
Zhu LY; Zhong KB; Lu SX; He LY
Zhonghua Nan Ke Xue; 2010 Sep; 16(9):794-8. PubMed ID: 21171262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
